MORGAN STANLEY PLC/CALL/STRYKER CORP./400/0.1/20.12.24 Stock

Warrant

DE000MB38BF5

Real-time Bid/Ask 11:00:49 2024-07-12 am EDT
0.43 EUR / 0.5 EUR +10.71% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./400/0.1/20.12.24
1 month-30.00%
3 months-63.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.41 -2.38%
24-07-11 0.42 -2.33%
24-07-10 0.43 +7.50%
24-07-09 0.4 0.00%
24-07-08 0.4 -6.98%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 05:23 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN MB38BF
ISINDE000MB38BF5
Date issued 2023-02-03
Strike 400 $
Maturity 2024-12-20 (161 Days)
Parity 10 : 1
Emission price 1.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.89
Lowest since issue 0.3
Spread 0.07
Spread %14.58%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
338.1 USD
Average target price
372.4 USD
Spread / Average Target
+10.16%
Consensus